FORNASIERO, ARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.138
EU - Europa 311
AS - Asia 113
AF - Africa 15
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.584
Nazione #
US - Stati Uniti d'America 1.132
IT - Italia 134
IN - India 64
SE - Svezia 55
CN - Cina 34
FI - Finlandia 26
DE - Germania 19
GB - Regno Unito 15
TG - Togo 15
FR - Francia 14
UA - Ucraina 12
BG - Bulgaria 10
NL - Olanda 7
HK - Hong Kong 6
RO - Romania 6
SG - Singapore 6
AR - Argentina 5
CA - Canada 4
CH - Svizzera 4
IE - Irlanda 4
ES - Italia 3
MK - Macedonia 2
PR - Porto Rico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
JP - Giappone 1
KG - Kirghizistan 1
TR - Turchia 1
Totale 1.584
Città #
Fairfield 178
Chandler 120
Ashburn 96
Woodbridge 88
Cambridge 67
Houston 64
Seattle 55
Wilmington 53
Princeton 32
Rome 31
Dearborn 28
Fasano 22
Plano 22
San Diego 22
Beijing 21
Ann Arbor 18
Millbury 16
Lawrence 15
Lomé 15
Helsinki 14
New York 14
Pune 14
Boston 13
Bremen 12
Norwalk 12
Andover 11
San Paolo di Civitate 11
Sofia 10
Des Moines 8
Hong Kong 6
Paris 6
Milan 5
Phoenix 5
Dublin 4
Federal 4
Toronto 4
Boardman 3
London 3
Madrid 3
Porcari 3
Winterthur 3
Bühl 2
Cerro Maggiore 2
Chengdu 2
Giugliano In Campania 2
Guangzhou 2
Jacksonville 2
Prilep 2
Redmond 2
San Jose 2
Sassuolo 2
Shoreham-by-sea 2
Singapore 2
Teramo 2
Wuhan 2
Atlanta 1
Avella 1
Bad Bellingen 1
Bishkek 1
Boulder 1
Capena 1
Carpineto Romano 1
Champs-sur-marne 1
Changsha 1
Conegliano 1
Contigliano 1
Ercolano 1
Florence 1
Fremont 1
Fuzhou 1
Hefei 1
Hunedoara 1
Istanbul 1
Kunming 1
La Rioja 1
Lyon 1
Magenta 1
Nanchang 1
Nuremberg 1
Philadelphia 1
Pomezia 1
Poplar 1
Provo 1
Redwood City 1
Ruvo Di Puglia 1
San Mateo 1
San Pablo 1
Shrewsbury 1
Solagna 1
Southend 1
Southwark 1
Wageningen 1
Xian 1
Zurich 1
Totale 1.198
Nome #
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study 107
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients 96
IFN-β and multiple sclerosis: From etiology to therapy and back 92
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 77
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia 76
Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report 73
The contribution of gut barrier changes to multiple sclerosis pathophysiology 72
Vaccines in multiple sclerosis. The experience of BCG vaccination 71
IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status 70
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 69
Intestinal Permeabiliy in Relapsing-Remitting Multiple Sclerosis 69
Genome-Wide Multiple Sclerosis Association Data and Coagulation 69
Chemical Elements and Oxidative Status in Neuroinflammation 68
Disentangling the molecular mechanisms of multiple sclerosis: the contribution of twin studies 64
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study 62
null 60
Autoimmune encephalitis and CSF anti-glur3 antibodies in an MS patient after alemtuzumab treatment 58
Chapter 3 - Bacille Calmette-Guérin (BCG) Vaccine in Neuroinflammation 58
Seropositive myasthenia gravis (MG): is there a changing trend in the age at onset? 57
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 55
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate 52
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis. 47
Intracellular insulin mediated signalling in Myotonic Dystrophy type 1 (DM1) 45
Intracellular insulin mediated signaling in myotonic dystrophy type 1 42
Effects of Mexiletine on cardiac parameters, muscle strenght and myotonia in Myotonic Dystrophy 40
Interferon-b therapy differently modulates Toll-like receptor 7 and 9- induced differentiation of B lymphocytes in multiple sclerosis patients 30
Metodo di studio della via intracellulare insulino-mediata nella Distrofia Miotonica tipo 1 (DM1) 21
Leptomeningitis in a person with radiologically isolated syndrome and latent tuberculosis. A case report with implications for clinical research 10
Totale 1.710
Categoria #
all - tutte 4.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019122 0 0 0 0 0 0 0 0 0 27 51 44
2019/2020418 49 27 4 35 39 57 53 51 48 32 19 4
2020/2021131 15 13 7 4 16 7 7 19 11 23 7 2
2021/2022349 6 15 31 13 60 7 10 33 17 19 86 52
2022/2023354 58 64 27 49 47 36 4 17 30 6 13 3
2023/2024158 8 19 4 12 14 50 10 29 3 9 0 0
Totale 1.710